Targeting homologous recombination-mediated DNA repair in cancer
Author:
Publisher
Informa Healthcare
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/14728222.2014.882900
Reference244 articles.
1. Combinatorial drug therapy for cancer in the post-genomic era
2. DNA repair pathways as targets for cancer therapy
3. DNA repair dysregulation from cancer driver to therapeutic target
4. Quantitative Live Cell Imaging Reveals a Gradual Shift between DNA Repair Mechanisms and a Maximal Use of HR in Mid S Phase
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Design and Spectral Validation of RAD51 Inhibitors Based on BRC4 (1523-1546);Pharmaceutical Chemistry Journal;2024-06
2. Efficacy and safety of PARP inhibitors in the treatment of BRCA-mutated breast cancer: an updated systematic review and meta-analysis of randomized controlled trials;Expert Review of Clinical Pharmacology;2023-03-04
3. Germline mutation landscape of DNA damage repair genes in African Americans with prostate cancer highlights potentially targetable RAD genes;Nature Communications;2022-03-15
4. Analysis of Machine Learning Techniques for Detection Framework for DNA Repair Genes to help Diagnose Cancer: A Systematic Literature Review;2021 International Conference on Innovative Computing (ICIC);2021-11-09
5. DNA Double Strand Break Repair Pathways in Response to Different Types of Ionizing Radiation;Frontiers in Genetics;2021-09-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3